Presentation Information
[O17-04]An Interim report of 50 cases of post-marketing surveillance of Lisdexamfetamine in pediatric ADHD.
○Ryoko Otani1,2, Takeshi Inoue1, Nozomi Omori1, Naho Matsushima1, Ryoichi Sakuta1 (1.Child Development and Psychosomatic Medical Center, Saitama, Japan, 2.Oji clinic)